Genmab A (GMAB) Current Assets: 2018-2021
- Genmab A's Current Assets rose 21.99% to $2,411 in Q2 2021 from the same period last year, while for Jun 2021 it was $2,411, marking a year-over-year increase of 21.99%. This contributed to the annual value of $2.2 billion for FY2020, which is 53.02% up from last year.
- Latest data reveals that Genmab A reported Current Assets of $2,411 as of Q2 2021, which was down 100.00% from $2.2 billion recorded in Q4 2020.
- Genmab A's 5-year Current Assets high stood at $2.2 billion for Q4 2020, and its period low was $1,976 during Q2 2020.
- Moreover, its 3-year median value for Current Assets was $827.5 million (2019), whereas its average is $884.8 million.
- Its Current Assets has fluctuated over the past 5 years, first spiked by 72.97% in 2019, then tumbled by 100.00% in 2020.
- Over the past 4 years, Genmab A's Current Assets (Quarterly) stood at $821.8 million in 2018, then soared by 72.97% to $1.4 billion in 2019, then soared by 53.02% to $2.2 billion in 2020, then rose by 21.99% to $2,411 in 2021.
- Its Current Assets was $2,411 in Q2 2021, compared to $2.2 billion in Q4 2020 and $1,976 in Q2 2020.
